Primary record
(3R,11S)-6-fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentaazatetracyclo[13.5.2.0?,?.0(1)?,(2)(2)]docosa-1(21),4,6,8,15(22),16,19-heptaen-14-one
- 库存
- 6,789 克
- 纯度
- 99.2 %
- CAS
- 1802220-02-5
化合物标识与属性
- CAS
- 1802220-02-5
- PubChem CID
- 135565923
- SMILES
- C[C@H]1CNC(=O)C2=C3N=C(C=CN3N=C2)N[C@@H](C4=C(O1)C=CC(=C4)F)C
- Canonical SMILES
- C[C@H]1CNC(=O)c2cnn3ccc(nc23)N[C@H](C)c2cc(F)ccc2O1
名称与同义词
- Repotrectinib
- Ropotrectinib
- Augtyro
- TPX-0005
- repotrectinibum
- 1802220-02-5
- Augtyro (TN)
- Repotrectinib [USAN]
- 08O3FQ4UNP
- Repotrectinib(TPX-005)
- RefChem:178876
- UNII-08O3FQ4UNP
- REPOTRECTINIB [INN]
- Repotrectinib (JAN/USAN)
- TPX0005
- Repotrectinib (TPX-0005)
- REPOTRECTINIB [WHO-DD]
- orb1303198
- CHEMBL4298138
- SCHEMBL16946804
- SCHEMBL29358351
- TRX-0005
- C18H18FN5O2
- GTPL10316
- Multikinase Inhibitor TPX-0005
- CHEBI:229220
- TPX 0005 [WHO-DD]
- BDBM374727
- DTXSID001358953
- Multi-kinase Inhibitor TPX-0005
- CXC22002
- EX-A2572
- TPX 0005
- US10246466, Example 93
- MFCD31544350
- NSC800522
- s8583
- AKOS037648789
- CCG-268096
- CS-7628
- NSC-800522
- AC-31283
- BS-15622
- example 93 [US20170334929A1]
- HY-103022
- (3R,11S)-6-fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentazatetracyclo[13.5.2.04,9.018,22]docosa-1(21),4(9),5,7,15(22),16,19-heptaen-14-one
- C73438
- D11454
- A910911
- 1,15-Etheno-1H-pyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one,11-fluoro-6,7,13,14-tetrahydro-7,13-dimethyl-, (7S,13R)-
- ALK/ROS1/NTRK/SRC/FAK Multikinase Inhibitor TPX-0005
- B2693-007261
- (7S,13R)-11-fluoro-6,7,13,14-tetrahydro-7,13-dimethyl-1,15-etheno-1H-pyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one
- 1,15-Etheno-1H-pyrazolo(4,3-F)(1,4,8,10)benzoxatriazacyclotridecin-4(5H)-one, 11-fluoro-6,7,13,14-tetrahydro-7,13-dimethyl-, (7S,13R)-
- (13E,14E,3R,6S)-45-fluoro-3,6-dimethyl-5-oxa-2,8-diaza-1(5,3)-pyrazolo[1,5-a]pyrimidina-4(1,2)-benzenacyclononaphan-9-one
- 1,15-Etheno-1H-pyrazolo(4,3-f)(1,4,8,10)benzoxatriazacyclotridecin-4(5H)-one, 11-fluoro-2,6,7,13-tetrahydro-7,13-dimethyl-, (14Z)-
- (13E,14E,3R,6S)-45-fluoro-3,6-dimethyl-5-oxa-2,8-diaza-1(5,3)pyrazolo[1,5-a]pyrimidina-4(1,2)-benzenacyclononaphan-9-one
- (1Z)-6-Fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentaazatetracyclo(13.5.2.04,9.018,22)docosa-1,4,6,8,15,19,21-heptaen-14-one
- (3R,11S)-6-fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentaazatetracyclo[13.5.2.0,.0,]docosa-1(21),4(9),5,7,15(22),16,19-heptaen-14-one
- (3R,11S)-6-fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentaazatetracyclo[13.5.2.0?,?.0(1)?,(2)(2)]docosa-1(21),4,6,8,15(22),16,19-heptaen-14-one
- (3R,11S)-6-fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentazatetracyclo(13.5.2.04,9.018,22)docosa-1(21),4(9),5,7,15(22),16,19-heptaen-14-one
- (3R,6S,)-45-FLUORO-3,6-DIMETHYL-5-OXA-2,8-DIAZA-1(5,3)-PYRAZOLO(1,5-A)PYRIMIDINA-4(1,2)-BENZENANONAPHAN-9-ONE
- (3R,6S,)-45-Fluoro-3,6-dimethyl-5-oxa-2,8-diaza-1(5,3)-pyrazolo[1,5-a]pyrimidina-4(1,2)-benzenanonaphan-9-one
- (7S,13R)-11-fluoro-7,13-dimethyl-6,7,13,14- tetrahydro-1,15-ethenopyrazolo[4,3- f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)- one
- NO